Pulmonary Function Testing in Neuromuscular and Chest Wall Disorders
Overview
Authors
Affiliations
Neuromuscular and chest wall disorders frequently compromise pulmonary function, and thorough respiratory evaluation often can assist in diagnosis, risk assessment, and prognosis. Because many of these disorders can be progressive, serial assessments are necessary to best define a trajectory of impairment (or improvement with therapy). This article covers the major respiratory testing modalities available in the evaluation of these patients, emphasizing both the benefits and shortcomings of each approach. Most parameters are available in a standard pulmonary laboratory (flows, volumes, static pressures), although referral to a specialized center may be necessary to conclusively evaluate a given patient.
Nelson R, Richards J ATS Sch. 2023; 4(2):230-240.
PMID: 37538069 PMC: 10394713. DOI: 10.34197/ats-scholar.2022-0062HT.
Sleep apnoea and hypoventilation in patients with five major types of muscular dystrophy.
Li L, Umbach D, Li Y, Halani P, Shi M, Ahn M BMJ Open Respir Res. 2023; 10(1).
PMID: 37072321 PMC: 10124300. DOI: 10.1136/bmjresp-2022-001506.
Sajjadi E, Mabe P, Seven Y, Smith B Cardiopulm Phys Ther J. 2022; 33(2):87-95.
PMID: 36148286 PMC: 9488548. DOI: 10.1097/cpt.0000000000000183.
Marts L, Staitieh B Ann Am Thorac Soc. 2018; 16(1):132-137.
PMID: 30592455 PMC: 6344459. DOI: 10.1513/AnnalsATS.201807-450CC.